Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...
Researchers from VIB and VUB now provide an interactive tool, based on a single-cell RNA-sequencing (scRNA-seq) atlas of the ...
Although myeloma is treatable, it is generally not curable, and advanced therapies like blood stem cell transplantation can ...
The department used its new system for determining whether a condition is service-connected to give affected veterans access ...
Dr Braunstein, how would her cytogenetics and [disease] stage impact these treatment decisions ... This looked at patients ...
GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects a multi-blockbuster ...
Stand Up To Cancer® (SU2C) today announced a collaboration with Johnson & Johnson aimed at supporting research testing a ...
The marketing applications with the EMA and FDA are for J&J and partner Genmab's Darzalex Faspro version of the anti-CD38 ...
Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...
If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.
Binod Dhakal, MD, MS, discusses some of the next steps for evaluating ciltacabtagene autoleucel in multiple myeloma and the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback